✦ LIBER ✦

Treatment of Refractory Adult Acute Lymphocytic Leukaemia and Acute Undifferentiated Leukaemia with an Anthracycline Antibiotic and Cytosine Arabinoside

✍ Scribed by Amy Papalia Early; H. D. Preisler; Arlin J. Gottlieb; Neil A. Lanchant

Book ID: 114709465
Publisher: John Wiley and Sons
Year: 1981
Tongue: English
Weight: 501 KB
Volume: 48
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1981.tb02728.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TREATMENT OF REFRACTORY ACUTE LEUKAEMIA

TREATMENT OF REFRACTORY ACUTE LEUKAEMIA WITH HIGH DOSE CYTOSINE ARABINOSIDE

✍ R. Willemze; F. E. Zwaan; J. J. Keuning; G. Colpin 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Treatment of relapsed and refractory acu

Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

✍ Martin Gore; Ray Powles; Anil Lakhani; Sarah Milan; Jennifer Maitland; Glen Goss 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 425 KB

A total of 65 patients under the age of 55 with acute leukaemia received high-dose cytosine arabinoside (Ara-C) in combination with high-dose etoposide without an anthracycline. Complete remission rates for patients with relapsed or refractory acute myelogenous leukaemia (AML) were 15/25 (60%) and 1

Treatment of Acute Myeloid Leukaemia wit

Treatment of Acute Myeloid Leukaemia with Cytosine Arabinoside and Daunomycin in Combination

✍ BRINCKER, HANS 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) ⚖ 391 KB

Clofarabine and high-dose cytosine arabi

Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia

✍ Eric Tse; Anskar Y. H. Leung; Joycelyn Sim; Harold K. K. Lee; Herman S. Y. Liu; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 98 KB

Clofarabine (40 mg/m^2^/day × 5) and high-dose cytosine arabinoside (Ara-C, 1–2 g/m^2^/day × 5) were used in 10 men and 11 women, at a median age of 45 (22–62) years, with refractory (__N__ = 4) and relapsed (__N__ = 17) acute myeloid leukaemia, after a median of 3 (2–5) prior regimens. Grade 4 myel

PREDICTION OF RESPONSE OF ACUTE NON-LYMP

PREDICTION OF RESPONSE OF ACUTE NON-LYMPHOCYTIC LEUKAEMIA TO THERAPY WITH ‘HIGH DOSE’ CYTOSINE ARABINOSIDE

✍ W. G. Peters; R. Willemze; L. P. Colly; L. Colla 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Idarubicin and standard-dose cytosine ar

Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia

✍ Merat Karbasian-Esfahani; Peter H. Wiernik; Yelena Novik; Elisabeth Paietta; Jan 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

## Abstract ## BACKGROUND Drug resistance and early disease recurrence were major contributing factors in the limited survival of patients with acute lymphocytic leukemia (ALL). New chemotherapeutic agents and drug combinations were employed in refractory patients to overcome drug resistance. ##